3,803
Views
54
CrossRef citations to date
0
Altmetric
Review Article

Neurobiology of depression: A neurodevelopmental approach

, &
Pages 349-359 | Received 22 Mar 2016, Accepted 26 Jan 2017, Published online: 03 Mar 2017

References

  • Ader R, Cohen N, Felten D. 1995. Psychoneuroimmunology: interactions between the nervous system and the immune system. Lancet. 345:99–103.
  • Anderson AL, Thomason ME. 2013. Functional plasticity before the cradle: a review of neural functional imaging in the human fetus. Neurosci Biobehav Rev. 37:2220–2232.
  • Anokhin AP, Birbaumer N, Lutzenberger W, Nikolaev A, Vogel F. 1996. Age increases brain complexity. Electroencephalogr Clin Neurophysiol. 99:63–68.
  • Ansorge MS, Hen R, Gingrich JA. 2007. Neurodevelopmental origins of depressive disorders. Curr Opin Pharmacol. 7:8–17.
  • Ansorge MS, Morelli E, Gingrich JA. 2008. Inhibition of serotonin but not norepinephrine transport during development produces delayed, persistent perturbations of emotional behaviors in mice. J Neurosci. 28:199–207.
  • Bale TL, Baram TZ, Brown AS, Goldstein JM, Insel TR, McCarthy MM, Nemeroff CB, Reyes TM, Simerly RB, Susser ES, et al. 2010. Early life programming and neurodevelopmental disorders. Biol Psychiatry. 68:314–319.
  • Belmaker RH, Agam G. 2008. Major depressive disorder. N Engl J Med. 358:55–68.
  • Bilbo SD. 2013. Frank A. Beach award: programming of neuroendocrine function by early-life experience: a critical role for the immune system. Horm Behav. 63:684–691.
  • Bilbo SD, Schwarz JM. 2012. The immune system and developmental programming of brain and behavior. Front Neuroendocrinol. 33:267–286.
  • Booij L, Szyf M, Carballedo A, Frey EM, Morris D, Dymov S, Vaisheva F, Ly V, Fahey C, Meaney J, et al. 2015. DNA methylation of the serotonin transporter gene in peripheral cells and stress-related changes in hippocampal volume: a study in depressed patients and healthy controls. PLoS One. 10:e0119061.
  • Bora E, Fornito A, Pantelis C, Yucel M. 2012. Gray matter abnormalities in Major Depressive Disorder: a meta-analysis of voxel based morphometry studies. J Affect Disord. 138:9–18.
  • Boulanger LM. 2009. Immune proteins in brain development and synaptic plasticity. Neuron. 64:93–109.
  • Bradley RG, Binder EB, Epstein MP, Tang Y, Nair HP, Liu W, Gillespie CF, Berg T, Evces M, Newport DJ, et al. 2008. Influence of child abuse on adult depression: moderation by the corticotropin-releasing hormone receptor gene. Arch Gen Psychiatry. 65:190–200.
  • Brambilla F. 2000. Psychoneurendocrinology: a science of the past or a new pathway for the future? Eur J Pharmacol. 405:341–349.
  • Campbell S, Marriott M, Nahmias C, MacQueen GM. 2004. Lower hippocampal volume in patients suffering from depression: a meta-analysis. Am J Psychiatry. 161:598–607.
  • Carver CS, Johnson SL, Joormann J, Lemoult J, Cuccaro ML. 2011. Childhood adversity interacts separately with 5-HTTLPR and BDNF to predict lifetime depression diagnosis. J Affect Disord. 132:89–93.
  • Casey BJ, Giedd JN, Thomas KM. 2000. Structural and functional brain development and its relation to cognitive development. Biol Psychol. 54:241–257.
  • Caspi A, Sugden K, Moffitt TE, Taylor A, Craig IW, Harrington H, McClay J, Mill J, Martin J, Braithwaite A, et al. 2003. Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science. 301:386–389.
  • Castren E, Voikar V, Rantamaki T. 2007. Role of neurotrophic factors in depression. Curr Opin Pharmacol. 7:18–21.
  • Chaouloff F. 2000. Serotonin, stress and corticoids. J Psychopharmacol (Oxford). 14:139–151.
  • Checkley S. 1996. The neuroendocrinology of depression and chronic stress. Br Med Bull. 52:597–617.
  • Clouston TS. 1891. The neuroses of development: being the Morison lectures for 1890. Edinburgh: Oliver & Boyd; Simpkin, Marshall, Hamilton, Kent, & Co.
  • Cole J, Costafreda SG, McGuffin P, Fu CH. 2011. Hippocampal atrophy in first episode depression: a meta-analysis of magnetic resonance imaging studies. J Affect Disord. 134:483–487.
  • Cotter D, Mackay D, Chana G, Beasley C, Landau S, Everall IP. 2002. Reduced neuronal size and glial cell density in area 9 of the dorsolateral prefrontal cortex in subjects with major depressive disorder. Cereb Cortex. 12:386–394.
  • Dantzer R, O'Connor JC, Freund GG, Johnson RW, Kelley KW. 2008. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci. 9:46–56.
  • Davidson RJ, Pizzagalli D, Nitschke JB, Putnam K. 2002. Depression: perspectives from affective neuroscience. Annu Rev Psychol. 53:545–574.
  • Davies AM. 1994. The role of neurotrophins in the developing nervous system. J Neurobiol. 25:1334–1348.
  • Duman RS. 2004. Role of neurotrophic factors in the etiology and treatment of mood disorders. Neuromolecular Med. 5:11–25.
  • Elson AE, Simerly RB. 2015. Developmental specification of metabolic circuitry. Front Neuroendocrinol. 39:38–51.
  • Essex MJ, Boyce WT, Hertzman C, Lam LL, Armstrong JM, Neumann SM, Kobor MS. 2013. Epigenetic vestiges of early developmental adversity: childhood stress exposure and DNA methylation in adolescence. Child Dev. 84:58–75.
  • Fagiolini M, Jensen CL, Champagne FA. 2009. Epigenetic influences on brain development and plasticity. Curr Opin Neurobiol. 19:207–212.
  • Fava GA, Grandi S, Canestrari R, Molnar G. 1990. Prodromal symptoms in primary major depressive disorder. J Affect Disord. 19:149–152.
  • Gale CR, Martyn CN. 2004. Birth weight and later risk of depression in a national birth cohort. Br J Psychiatry. 184:28–33.
  • Garza JC, Guo M, Zhang W, Lu XY. 2012. Leptin restores adult hippocampal neurogenesis in a chronic unpredictable stress model of depression and reverses glucocorticoid-induced inhibition of GSK-3beta/beta-catenin signaling. Mol Psychiatry. 17:790–808.
  • Gaspar P, Cases O, Maroteaux L. 2003. The developmental role of serotonin: news from mouse molecular genetics. Nat Rev Neurosci. 4:1002–1012.
  • Gatt JM, Nemeroff CB, Dobson-Stone C, Paul RH, Bryant RA, Schofield PR, Gordon E, Kemp AH, Williams LM. 2009. Interactions between BDNF Val66Met polymorphism and early life stress predict brain and arousal pathways to syndromal depression and anxiety. Mol Psychiatry. 14:681–695.
  • Giedd JN, Blumenthal J, Jeffries NO, Castellanos FX, Liu H, Zijdenbos A, Paus T, Evans AC, Rapoport JL. 1999. Brain development during childhood and adolescence: a longitudinal MRI study. Nat Neurosci. 2:861–863.
  • Gogtay N, Giedd JN, Lusk L, Hayashi KM, Greenstein D, Vaituzis AC, Nugent TF 3rd, Herman DH, Clasen LS, Toga AW, et al. 2004. Dynamic mapping of human cortical development during childhood through early adulthood. Proc Natl Acad Sci USA. 101:8174–8179.
  • Groves JO. 2007. Is it time to reassess the BDNF hypothesis of depression? Mol Psychiatry. 12:1079–1088.
  • Gryglewski G, Lanzenberger R, Kranz GS, Cumming P. 2014. Meta-analysis of molecular imaging of serotonin transporters in major depression. J Cereb Blood Flow Metab. 34:1096–1103.
  • Haghighi F, Bach-Mizrachi H, Huang YY, Arango V, Shi S, Dwork AJ, Rosoklija G, Sheng HT, Morozova I, Ju J, et al. 2008. Genetic architecture of the human tryptophan hydroxylase 2 Gene: existence of neural isoforms and relevance for major depression. Mol Psychiatry. 13:813–820.
  • Hall J, Thomas KL, Everitt BJ. 2000. Rapid and selective induction of BDNF expression in the hippocampus during contextual learning. Nat Neurosci. 3:533–535.
  • Hamilton JP, Siemer M, Gotlib IH. 2008. Amygdala volume in major depressive disorder: a meta-analysis of magnetic resonance imaging studies. Mol Psychiatry. 13:993–1000.
  • Handel AE, Ebers GC, Ramagopalan SV. 2010. Epigenetics: molecular mechanisms and implications for disease. Trends Mol Med. 16:7–16.
  • Harkness KL, Stewart JG, Wynne-Edwards KE. 2011. Cortisol reactivity to social stress in adolescents: role of depression severity and child maltreatment. Psychoneuroendocrinology. 36:173–181.
  • Henderson CE. 1996. Role of neurotrophic factors in neuronal development. Curr Opin Neurobiol. 6:64–70.
  • Heninger GR, Delgado PL, Charney DS. 1996. The revised monoamine theory of depression: a modulatory role for monoamines, based on new findings from monoamine depletion experiments in humans. Pharmacopsychiatry. 29:2–11.
  • Holsboer F. 2000. The corticosteroid receptor hypothesis of depression. Neuropsychopharmacology. 23:477–501.
  • Huang EJ, Reichardt LF. 2001. Neurotrophins: roles in neuronal development and function. Annu Rev Neurosci. 24:677–736.
  • Jackson A, Cavanagh J, Scott J. 2003. A systematic review of manic and depressive prodromes. J Affect Disord. 74:209–217.
  • Judd LL, Akiskal HS, Paulus MP. 1997. The role and clinical significance of subsyndromal depressive symptoms (SSD) in unipolar major depressive disorder. J Affect Disord. 45:5–17.
  • Kang HJ, Kim JM, Stewart R, Kim SY, Bae KY, Kim SW, Shin IS, Shin MG, Yoon JS. 2013. Association of SLC6A4 methylation with early adversity, characteristics and outcomes in depression. Prog Neuropsychopharmacol Biol Psychiatry. 44:23–28.
  • Kapur S, Mann JJ. 1992. Role of the dopaminergic system in depression. Biol Psychiatry. 32:1–17.
  • Karege F, Bondolfi G, Gervasoni N, Schwald M, Aubry JM, Bertschy G. 2005. Low brain-derived neurotrophic factor (BDNF) levels in serum of depressed patients probably results from lowered platelet BDNF release unrelated to platelet reactivity. Biol Psychiatry. 57:1068–1072.
  • Kato T. 2007. Molecular genetics of bipolar disorder and depression. Psychiatry Clin Neurosci. 61:3–19.
  • Khan D, Fernando P, Cicvaric A, Berger A, Pollak A, Monje FJ, Pollak DD. 2014. Long-term effects of maternal immune activation on depression-like behavior in the mouse. Transl Psychiatry. 4:e363.
  • Kim JM, Stewart R, Kim SW, Yang SJ, Shin IS, Kim YH, Yoon JS. 2007. Interactions between life stressors and susceptibility genes (5-HTTLPR and BDNF) on depression in Korean elders. Biol Psychiatry. 62:423–428.
  • Koolschijn PC, van Haren NE, Lensvelt-Mulders GJ, Hulshoff Pol HE, Kahn RS. 2009. Brain volume abnormalities in major depressive disorder: a meta-analysis of magnetic resonance imaging studies. Hum Brain Mapp. 30:3719–3735.
  • Koutmani Y, Politis PK, Elkouris M, Agrogiannis G, Kemerli M, Patsouris E, Remboutsika E, Karalis KP. 2013. Corticotropin-releasing hormone exerts direct effects on neuronal progenitor cells: implications for neuroprotection. Mol Psychiatry. 18:300–307.
  • Kundakovic M, Gudsnuk K, Herbstman JB, Tang D, Perera FP, Champagne FA. 2015. DNA methylation of BDNF as a biomarker of early-life adversity. Proc Natl Acad Sci USA. 112:6807–6813.
  • Lenroot RK, Giedd JN. 2006. Brain development in children and adolescents: insights from anatomical magnetic resonance imaging. Neurosci Biobehav Rev. 30:718–729.
  • Lesch KP, Waider J. 2012. Serotonin in the modulation of neural plasticity and networks: implications for neurodevelopmental disorders. Neuron. 76:175–191.
  • Levinson DF. 2006. The genetics of depression: a review. Biol Psychiatry. 60:84–92.
  • Lima-Ojeda JM. 2014. Neurodevelopment and schizophrenia: pharmacological and behavioral animal models. Mannheim: Ruperto Carola University of Heidelberg; p. 77.
  • Lipsky RH, Marini AM. 2007. Brain-derived neurotrophic factor in neuronal survival and behavior-related plasticity. Ann NY Acad Sci. 1122:130–143.
  • Lohoff FW. 2010. Overview of the genetics of major depressive disorder. Curr Psychiatry Rep. 12:539–546.
  • Lopizzo N, Bocchio Chiavetto L, Cattane N, Plazzotta G, Tarazi FI, Pariante CM, Riva MA, Cattaneo A. 2015. Gene-environment interaction in major depression: focus on experience-dependent biological systems. Front Psychiatry. 6:68.
  • Lorenzetti V, Allen NB, Fornito A, Yucel M. 2009. Structural brain abnormalities in major depressive disorder: a selective review of recent MRI studies. J Affect Disord. 117:1–17.
  • Lu XY. 2007. The leptin hypothesis of depression: a potential link between mood disorders and obesity? Curr Opin Pharmacol. 7:648–652.
  • Mainardi M, Pizzorusso T, Maffei M. 2013. Environment, leptin sensitivity, and hypothalamic plasticity. Neural Plast. 2013:438072.
  • Maniam J, Antoniadis C, Morris MJ. 2014. Early-life stress, HPA axis adaptation, and mechanisms contributing to later health outcomes. Front Endocrinol (Lausanne). 5:73.
  • Martinowich K, Lu B. 2008. Interaction between BDNF and serotonin: role in mood disorders. Neuropsychopharmacology. 33:73–83.
  • Martinowich K, Manji H, Lu B. 2007. New insights into BDNF function in depression and anxiety. Nat Neurosci. 10:1089–1093.
  • Massart R, Mongeau R, Lanfumey L. 2012. Beyond the monoaminergic hypothesis: neuroplasticity and epigenetic changes in a transgenic mouse model of depression. Philos Trans R Soc Lond B Biol Sci. 367:2485–2494.
  • Melas PA, Wei Y, Wong CC, Sjoholm LK, Aberg E, Mill J, Schalling M, Forsell Y, Lavebratt C. 2013. Genetic and epigenetic associations of MAOA and NR3C1 with depression and childhood adversities. Int J Neuropsychopharmacol. 16:1513–1528.
  • Mitchelmore C, Gede L. 2014. Brain derived neurotrophic factor: epigenetic regulation in psychiatric disorders. Brain Res. 1586:162–172.
  • Money KM, Stanwood GD. 2013. Developmental origins of brain disorders: roles for dopamine. Front Cell Neurosci. 7:260.
  • Mulinari S. 2012. Monoamine theories of depression: historical impact on biomedical research. J Hist Neurosci. 21:366–392.
  • Murgatroyd C, Spengler D. 2011a. Epigenetic programming of the HPA axis: early life decides. Stress. 14:581–589.
  • Murgatroyd C, Spengler D. 2011b. Epigenetics of early child development. Front Psychiatry. 2:16.
  • Nanni V, Uher R, Danese A. 2012. Childhood maltreatment predicts unfavorable course of illness and treatment outcome in depression: a meta-analysis. Am J Psychiatry. 169:141–151.
  • O'Connor MJ, Paley B. 2006. The relationship of prenatal alcohol exposure and the postnatal environment to child depressive symptoms. J Pediatr Psychol. 31:50–64.
  • Oitzl MS, Champagne DL, van der Veen R, de Kloet ER. 2010. Brain development under stress: hypotheses of glucocorticoid actions revisited. Neurosci Biobehav Rev. 34:853–866.
  • Palazidou E. 2012. The neurobiology of depression. Br Med Bull. 101:127–145.
  • Park H, Poo MM. 2013. Neurotrophin regulation of neural circuit development and function. Nat Rev Neurosci. 14:7–23.
  • Patten SB. 1991. The loss of a parent during childhood as a risk factor for depression. Can J Psychiatry. 36:706–711.
  • Paus T, Keshavan M, Giedd JN. 2008. Why do many psychiatric disorders emerge during adolescence? Nat Rev Neurosci. 9:947–957.
  • Pomeroy SL, Kim JY. 2000. Biology and pathobiology of neuronal development. Ment Retard Dev Disabil Res Rev. 6:41–46.
  • Powell WT, LaSalle JM. 2015. Epigenetic mechanisms in diurnal cycles of metabolism and neurodevelopment. Hum Mol Genet. 24(Suppl R1):R1–R9.
  • Rajkowska G, Miguel-Hidalgo JJ, Wei J, Dilley G, Pittman SD, Meltzer HY, Overholser JC, Roth BL, Stockmeier CA. 1999. Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression. Biol Psychiatry. 45:1085–1098.
  • Rice D, Barone S Jr. 2000. Critical periods of vulnerability for the developing nervous system: evidence from humans and animal models. Environ Health Perspect. 108(Suppl 3):511–533.
  • Rice F, Harold G, Thapar A. 2002. The genetic aetiology of childhood depression: a review. J Child Psychol Psychiatry. 43:65–79.
  • Rogers J, Raveendran M, Fawcett GL, Fox AS, Shelton SE, Oler JA, Cheverud J, Muzny DM, Gibbs RA, Davidson RJ, et al. 2013. CRHR1 genotypes, neural circuits and the diathesis for anxiety and depression. Mol Psychiatry. 18:700–707.
  • Sallert M, Rantamaki T, Vesikansa A, Anthoni H, Harju K, Yli-Kauhaluoma J, Taira T, Castren E, Lauri SE. 2009. Brain-derived neurotrophic factor controls activity-dependent maturation of CA1 synapses by downregulating tonic activation of presynaptic kainate receptors. J Neurosci. 29:11294–11303.
  • Semple BD, Blomgren K, Gimlin K, Ferriero DM, Noble-Haeusslein LJ. 2013. Brain development in rodents and humans: Identifying benchmarks of maturation and vulnerability to injury across species. Prog Neurobiol. 106–107:1–16.
  • Sen S, Duman R, Sanacora G. 2008. Serum brain-derived neurotrophic factor, depression, and antidepressant medications: meta-analyses and implications. Biol Psychiatry. 64:527–532.
  • Shinozaki G, Romanowicz M, Mrazek DA, Kung S. 2013. HTR2A gene-child abuse interaction and association with a history of suicide attempt among Caucasian depressed psychiatric inpatients. J Affect Disord. 150:1200–1203.
  • Silberg J, Rutter M, Neale M, Eaves L. 2001. Genetic moderation of environmental risk for depression and anxiety in adolescent girls. Br J Psychiatry. 179:116–121.
  • Skjelstad DV, Malt UF, Holte A. 2010. Symptoms and signs of the initial prodrome of bipolar disorder: a systematic review. J Affect Disord. 126:1–13.
  • Stieg MR, Sievers C, Farr O, Stalla GK, Mantzoros CS. 2015. Leptin: a hormone linking activation of neuroendocrine axes with neuropathology. Psychoneuroendocrinology. 51:47–57.
  • Stockmeier CA, Mahajan GJ, Konick LC, Overholser JC, Jurjus GJ, Meltzer HY, Uylings HB, Friedman L, Rajkowska G. 2004. Cellular changes in the postmortem hippocampus in major depression. Biol Psychiatry. 56:640–650.
  • Suri D, Teixeira CM, Cagliostro MK, Mahadevia D, Ansorge MS. 2015. Monoamine-sensitive developmental periods impacting adult emotional and cognitive behaviors. Neuropsychopharmacology. 40:88–112.
  • Tenyi T, Trixler M, Csabi G. 2009. Minor physical anomalies in affective disorders. A review of the literature. J Affect Disord. 112:11–18.
  • Thompson C, Syddall H, Rodin I, Osmond C, Barker DJ. 2001. Birth weight and the risk of depressive disorder in late life. Br J Psychiatry. 179:450–455.
  • Tsankova N, Renthal W, Kumar A, Nestler EJ. 2007. Epigenetic regulation in psychiatric disorders. Nat Rev Neurosci. 8:355–367.
  • Tsigos C, Chrousos GP. 2002. Hypothalamic-pituitary-adrenal axis, neuroendocrine factors and stress. J Psychosom Res. 53:865–871.
  • Uher R. 2014. Gene-environment interactions in severe mental illness. Front Psychiatry. 5:48.
  • Utge S, Soronen P, Partonen T, Loukola A, Kronholm E, Pirkola S, Nyman E, Porkka-Heiskanen T, Paunio T. 2010. A population-based association study of candidate genes for depression and sleep disturbance. Am J Med Genet B Neuropsychiatr Genet. 153B:468–476.
  • Van der Auwera S, Janowitz D, Schulz A, Homuth G, Nauck M, Volzke H, Rose M, Meyer zu Schwabedissen H, Freyberger HJ, Grabe HJ. 2014. Interaction among childhood trauma and functional polymorphisms in the serotonin pathway moderate the risk of depressive disorders. Eur Arch Psychiatry Clin Neurosci. 264(Suppl 1):S45–S54.
  • Videbech P, Ravnkilde B. 2004. Hippocampal volume and depression: a meta-analysis of MRI studies. Am J Psychiatry. 161:1957–1966.
  • Volpe JJ. 2000. Overview: normal and abnormal human brain development. Ment Retard Dev Disabil Res Rev. 6:1–5.
  • Weir JM, Zakama A, Rao U. 2012. Developmental risk I: depression and the developing brain. Child Adolesc Psychiatr Clin N Am. 21:237–259, vii.
  • Wellman CL, Izquierdo A, Garrett JE, Martin KP, Carroll J, Millstein R, Lesch KP, Murphy DL, Holmes A. 2007. Impaired stress-coping and fear extinction and abnormal corticolimbic morphology in serotonin transporter knock-out mice. J Neurosci. 27:684–691.
  • Whitaker-Azmitia PM. 2001. Serotonin and brain development: role in human developmental diseases. Brain Res Bull. 56:479–485.
  • Whitaker-Azmitia PM, Azmitia EC. 1986. Autoregulation of fetal serotonergic neuronal development: role of high affinity serotonin receptors. Neurosci Lett. 67:307–312.
  • Yap MB, Pilkington PD, Ryan SM, Jorm AF. 2014. Parental factors associated with depression and anxiety in young people: a systematic review and meta-analysis. J Affect Disord. 156:8–23.
  • Yu H, Chen ZY. 2011. The role of BDNF in depression on the basis of its location in the neural circuitry. Acta Pharmacol Sin. 32:3–11.
  • Yu Q, Teixeira CM, Mahadevia D, Huang Y, Balsam D, Mann JJ, Gingrich JA, Ansorge MS. 2014. Dopamine and serotonin signaling during two sensitive developmental periods differentially impact adult aggressive and affective behaviors in mice. Mol Psychiatry. 19:688–698.
  • Zhan J, Dinov ID, Li J, Zhang Z, Hobel S, Shi Y, Lin X, Zamanyan A, Feng L, Teng G, et al. 2013. Spatial-temporal atlas of human fetal brain development during the early second trimester. Neuroimage. 82:115–126.
  • Zhao X, Sun L, Sun YH, Ren C, Chen J, Wu ZQ, Jiang YH, Lv XL. 2014. Association of HTR2A T102C and A-1438G polymorphisms with susceptibility to major depressive disorder: a meta-analysis. Neurol Sci. 35:1857–1866.
  • Zunszain PA, Anacker C, Cattaneo A, Carvalho LA, Pariante CM. 2011. Glucocorticoids, cytokines and brain abnormalities in depression. Prog Neuropsychopharmacol Biol Psychiatry. 35:722–729.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.